Mesoporous Silica Nanoparticles‐Based Formulations for Enhanced Oral Delivery of Peptide Drugs: A Case Study on Insulin
Small · 2026
DOI: 10.1002/smll.202513347 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2026. Verfasst von Claudia Iriarte-Mesa und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Functional Materials and Catalysis, Faculty of Chemistry, University of Vienna, Vienna, Austria. Hauptthemen laut MEDLINE: Silicon Dioxide, Insulin, Nanoparticles, Peptides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Health and Medical Research Council, Australian Research Council, Austrian Science Fund.
Abstract (Originalsprache)
Peptide drugs have revolutionized modern medicine owing to their high potency, selectivity, and excellent tolerability. However, oral delivery remains limited, and most peptide drugs are administered parenterally due to their inherent instability to proteolytic digestion and poor ability to cross gastrointestinal barriers, which hinders efficient absorption into the bloodstream. This study presents a multifunctional oral delivery system based on mesoporous silica nanoparticles (MSN) customized for insulin administration. Insulin‐loaded MSN were co‐formulated with succinylated β‐lactoglobulin to produce pH‐responsive tablets that limited premature gastric release (≤13% after 2 h at pH 1.2) and protected insulin from enzymatic degradation, while enabling controlled intestinal release (up to 88%–98% at pH 7.4). Surface functionalization with polyethylene glycol and phosphonate moieties improved colloidal stability and increased insulin solubility by ∼2.5‐fold. The interaction of phosphonated MSN with intestinal epithelial cells further induced transient reorganization of tight junction proteins, enhancing paracellular insulin transport (26% after 24 h, compared with 13% for non‐confined insulin). Delivered insulin retained bioactivity, as demonstrated by activation of insulin‐responsive signaling pathways in vitro and reduced blood glucose levels in hyperglycemic mice. These results highlight MSN as a promising platform for oral peptide delivery with improved efficacy and patient compliance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Functional Materials and Catalysis, Faculty of Chemistry, University of Vienna, Vienna, Austria.
- Vienna Doctoral School in Chemistry (DoSChem), University of Vienna, Vienna, Austria.
- Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
- Joint Metabolome Facility, University of Vienna and Medical University of Vienna, Vienna, Austria.
- Institute of Biological Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria.
- Department of Environmental Toxicology, College of Agriculture and Environmental Science, University of California, Davis, California, USA.
ORCID-Profile: Claudia Iriarte-Mesa, Estelle Juère, Andrea Bileck, Thomas Kremsmayr, Michael L Goodson, Allison Ehrlich, Adnan Hodžić, Martin Kunert, Christopher Gerner, Hanspeter Kählig, Doris Marko, Markus Muttenthaler, David Berry, Giorgia Del Favero, Freddy Kleitz
Förderung
- National Health and Medical Research Council
- Australian Research Council
- Austrian Science Fund
- NIDDK NIH HHS
- University of Vienna
- European Research Council
- Universität Wien
Zitieren
APA
Iriarte-Mesa, C., Juère, E., Bileck, A., Kremsmayr, T., Goodson, M. L., Ehrlich, A., Hodžić, A., Kunert, M., Gerner, C., Kählig, H., Marko, D., Muttenthaler, M., Berry, D., Del Favero, G., & Kleitz, F. (2026). Mesoporous Silica Nanoparticles‐Based Formulations for Enhanced Oral Delivery of Peptide Drugs: A Case Study on Insulin. Small. https://doi.org/10.1002/smll.202513347
Vancouver
Iriarte-Mesa C, Juère E, Bileck A, Kremsmayr T, Goodson ML, Ehrlich A, et al. Mesoporous Silica Nanoparticles‐Based Formulations for Enhanced Oral Delivery of Peptide Drugs: A Case Study on Insulin. Small. 2026. doi:10.1002/smll.202513347
BibTeX
@article{IriarteMesa2026,
author = {Iriarte-Mesa, Claudia and Juère, Estelle and Bileck, Andrea and Kremsmayr, Thomas and Goodson, Michael L and Ehrlich, Allison and Hodžić, Adnan and Kunert, Martin and Gerner, Christopher and Kählig, Hanspeter and Marko, Doris and Muttenthaler, Markus and Berry, David and Del Favero, Giorgia and Kleitz, Freddy},
title = {Mesoporous Silica Nanoparticles‐Based Formulations for Enhanced Oral Delivery of Peptide Drugs: A Case Study on Insulin},
journal = {Small},
year = {2026},
doi = {10.1002/smll.202513347}
}
EUVIMED